| |
Ardea Biosciences, Inc. (RDEA)
|
| Last Traded At: |
$21.66
+
$0.55
|
| Volume: |
59,853 |
| Price/Earnings: |
$0.00 |
| Earnings Per Share: |
($1.59) |
| 52 Week High: |
$27.78 |
| 52 Week Low: |
$12.18 |
 |
| StockSpiker Coverage & Performance |
|
This stock has been covered by StockSpiker on the following dates. In addition, the percentage change from the coverage date and today's price is shown.
|
| Coverage |
Coverage
Date |
Gain Since Then |
|
|
|
|
|
|
|
|
|
|
|
|
|
| About Ardea Biosciences, Inc. |
| Ardea Biosciences, Inc., headquartered in San Diego, California, is a
biotechnology company focused on the discovery and development of small-molecule
therapeutics for the treatment of HIV, cancer and inflammatory diseases,
including gout. We believe that we are well-positioned to create shareholder
value through our development activities given our ability to achieve clinical
proof-of-concept relatively quickly and cost-effectively in these disease areas.
We are currently pursuing multiple development programs, including the
following:
Product Portfolio
Product candidate Target Indication Development Status
RDEA806 HIV Phase 2a
2nd generation NNRTI HIV Entering Phase 0
RDEA806 Gout Entering Phas |
 |
|
This website is intended to provide information only. If you are seeking advice on any matters relating to information on this website, you should - where appropriate - contact your broker or investment manager directly with your specific questions or seek advice from qualified Professional Financial advisor.
Whether you are a technical daytrader, or a long term fundamental investor, the StockSpiker gives you investment ideas based on the most relevant recent price
history of stocks. Here are some recent movers that we have reported on:
|
| |